Online citations, reference lists, and bibliographies.
← Back to Search

Magnetic Thrombolytic Ceramic Nanoparticles

A. S. Drozdov, V. Vinogradov
Published 2017 · Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Abstract The present study is devoted to the development of a new class of thrombolytic systems – magnetic thrombolytic ceramic nanoparticles. Indirect plasminogen activator, streptokinase, was entrapped into magnetite sol-gel matrix to produce magnetically-targetable solid-state thrombolytic agent with non-releasing behavior, demonstrating the prolonged effect. Based on the obtained composites, thrombolytic nanocolloids of nanoparticles with a size of less than 500 nm were produced. Resulting colloid is fully biocompatible, consists only of components approved for parenteral administration by FDA and EMA, and suitable for intravenous injection. Thrombolytic activity of the composites was studied on the plasminogen activation tests, lysis of human plasma clots and on a model thrombus made from whole human blood. Based on these results, a mechanism for activating entrapped streptokinase and the formation of the plasmin-streptokinase complex is suggested.
This paper references
Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis
E. Westein (2013)
Engineering of Plasmin-Resistant Forms of Streptokinase and Their Production in Bacillus subtilis: Streptokinase with Longer Functional Half-Life
X. Wu (1998)
Interaction of streptokinase with plasminogen. Isolation and characterization of a streptokinase degradation product.
G. Siefring (1976)
A universal magnetic ferrofluid: Nanomagnetite stable hydrosol with no added dispersants and at neutral pH.
A. S. Drozdov (2016)
Biocomposites for wound-healing based on sol–gel magnetite
A. S. Drozdov (2015)
Long‐term prognosis of late spontaneous reperfusion after failed thrombolysis for acute myocardial infarction
M. Ishihara (1999)
Streptokinase and recombinant tissue plasminogen activator (rt-PA) are equally effective in treating acute myocardial infarction.
S. Sherry (1991)
Enzymes and Other Proteins Entrapped in Sol-Gel Materials
D. Avnir (1994)
Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers.
J. Champion (2007)
Streptokinase@alumina nanoparticles as a promising thrombolytic colloid with prolonged action.
Yulia E. Chapurina (2016)
Entrapment of Enzymes within Sol–Gel-Derived Magnetite
A. S. Drozdov (2016)
Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis.
F. Bi (2009)
Leach-proof magnetic thrombolytic nanoparticles and coatings of enhanced activity
A. S. Drozdov (2016)
Streptokinase--a clinically useful thrombolytic agent.
A. Banerjee (2004)
Collagenase@magnetite: proteolytic composite for magnetically targeted minimally invasive surgery
E. M. Shabanova (2016)
A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
C. Grines (1993)
An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy.
Yoshiko Uesugi (2010)
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.
Y. Wáng (2011)
Studies on the isolation of the multiple molecular forms of human plasminogen and plasmin by isoelectric focusing methods.
L. Summaria (1972)
Rationale for a nanomedicine approach to thrombolytic therapy.
G. Lanza (2010)
Targeted thrombolysis by using of magnetic mesoporous silica nanoparticles.
M. Wang (2012)
Preparation and certain properties of highly purified streptokinase.
E. C. De Renzo (1967)
Characteristics of glycosylated streptokinase secreted from Pichia pastoris: enhanced resistance of SK to proteolysis by glycosylation
J. Pratap (2000)
Tissue plasminogen activator-based clot busting: Controlled delivery approaches
I. ElSherbiny (2014)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar